氟骨症的持续残废挑战-病例系列和文献综述

Q4 Medicine
Aneez Joseph, Remya Rajan, Jinson Paul, Kripa Elizabeth Cherian, Nitin Kapoor, Felix Jebasingh, Hesarghatta Shyamsunder Asha, Nihal Thomas, Thomas Vizhalil Paul
{"title":"氟骨症的持续残废挑战-病例系列和文献综述","authors":"Aneez Joseph,&nbsp;Remya Rajan,&nbsp;Jinson Paul,&nbsp;Kripa Elizabeth Cherian,&nbsp;Nitin Kapoor,&nbsp;Felix Jebasingh,&nbsp;Hesarghatta Shyamsunder Asha,&nbsp;Nihal Thomas,&nbsp;Thomas Vizhalil Paul","doi":"10.1016/j.jecr.2022.100114","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Skeletal fluorosis is a metabolic bone disease that results from the chronic ingestion of fluoride. Although there are national programs in place to raise awareness and curtail this disease condition, skeletal fluorosis continues to cause crippling deformities in areas where it continues to be endemic.</p></div><div><h3>Method</h3><p>ology: An observational study was undertaken at a university-affiliated teaching hospital in southern India. Clinical, biochemical features and densitometric variables including bone mineral density (BMD) and trabecular bone score (TBS) were assessed.</p></div><div><h3>Results</h3><p>All patients (n = 9) hailed from fluorosis-endemic Indian states and the source of drinking water was from a bore-well in all cases. The mean (±SD) age and BMI were 45.6(±11.0) years and 25.6 (±8.4) kg/m<sup>2</sup> respectively. Dental mottling was present in five subjects. Five subjects each had vitamin D deficiency with osteomalacia. The mean (±SD) urine fluoride was 2.9(±1.4) ppm. The bone mineral density showed a sclerotic pattern, with the mean (±SD) TBS being 1.607 (±0.160). All patients were initiated on calcium and cholecalciferol supplements and those with osteomalacia were treated with calcitriol.</p></div><div><h3>Conclusion</h3><p>While fluorosis continues to be a challenge in endemic regions, the presence of osteomalacia proves to be a treatable component of the disease condition. There seems to be an unmet need for more aggressive defluoridation techniques and the provision of safe drinking water in susceptible individuals.</p></div>","PeriodicalId":56186,"journal":{"name":"Journal of Clinical and Translational Endocrinology: Case Reports","volume":"24 ","pages":"Article 100114"},"PeriodicalIF":0.0000,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2214624522000089/pdfft?md5=6801bfe6e3a5d298bfe5764694e6a23c&pid=1-s2.0-S2214624522000089-main.pdf","citationCount":"2","resultStr":"{\"title\":\"The continuing crippling challenge of skeletal fluorosis – Case series and review of literature\",\"authors\":\"Aneez Joseph,&nbsp;Remya Rajan,&nbsp;Jinson Paul,&nbsp;Kripa Elizabeth Cherian,&nbsp;Nitin Kapoor,&nbsp;Felix Jebasingh,&nbsp;Hesarghatta Shyamsunder Asha,&nbsp;Nihal Thomas,&nbsp;Thomas Vizhalil Paul\",\"doi\":\"10.1016/j.jecr.2022.100114\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><p>Skeletal fluorosis is a metabolic bone disease that results from the chronic ingestion of fluoride. Although there are national programs in place to raise awareness and curtail this disease condition, skeletal fluorosis continues to cause crippling deformities in areas where it continues to be endemic.</p></div><div><h3>Method</h3><p>ology: An observational study was undertaken at a university-affiliated teaching hospital in southern India. Clinical, biochemical features and densitometric variables including bone mineral density (BMD) and trabecular bone score (TBS) were assessed.</p></div><div><h3>Results</h3><p>All patients (n = 9) hailed from fluorosis-endemic Indian states and the source of drinking water was from a bore-well in all cases. The mean (±SD) age and BMI were 45.6(±11.0) years and 25.6 (±8.4) kg/m<sup>2</sup> respectively. Dental mottling was present in five subjects. Five subjects each had vitamin D deficiency with osteomalacia. The mean (±SD) urine fluoride was 2.9(±1.4) ppm. The bone mineral density showed a sclerotic pattern, with the mean (±SD) TBS being 1.607 (±0.160). All patients were initiated on calcium and cholecalciferol supplements and those with osteomalacia were treated with calcitriol.</p></div><div><h3>Conclusion</h3><p>While fluorosis continues to be a challenge in endemic regions, the presence of osteomalacia proves to be a treatable component of the disease condition. There seems to be an unmet need for more aggressive defluoridation techniques and the provision of safe drinking water in susceptible individuals.</p></div>\",\"PeriodicalId\":56186,\"journal\":{\"name\":\"Journal of Clinical and Translational Endocrinology: Case Reports\",\"volume\":\"24 \",\"pages\":\"Article 100114\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S2214624522000089/pdfft?md5=6801bfe6e3a5d298bfe5764694e6a23c&pid=1-s2.0-S2214624522000089-main.pdf\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Clinical and Translational Endocrinology: Case Reports\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2214624522000089\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical and Translational Endocrinology: Case Reports","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2214624522000089","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 2

摘要

背景:氟骨症是一种代谢性骨病,由慢性摄入氟化物引起。虽然已经制定了提高认识和减少这种疾病的国家方案,但氟骨症继续在其流行的地区造成致残性畸形。方法:在印度南部的一所大学附属教学医院进行了一项观察性研究。评估临床、生化特征和密度测量变量,包括骨矿物质密度(BMD)和骨小梁评分(TBS)。结果9例患者均来自印度氟中毒地区,饮用水均来自一口井。平均(±SD)年龄为45.6(±11.0)岁,BMI为25.6(±8.4)kg/m2。5名受试者出现牙齿斑驳。五名受试者均患有维生素D缺乏症和骨软化症。尿氟平均(±SD)为2.9(±1.4)ppm。骨密度呈硬化型,TBS平均值(±SD)为1.607(±0.160)。所有患者开始服用钙和胆骨化醇补充剂,骨软化症患者服用骨化三醇。结论虽然氟中毒在流行地区仍然是一个挑战,但骨软化症的存在被证明是一种可治疗的疾病。对更积极的除氟技术和向易感人群提供安全饮用水的需求似乎尚未得到满足。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
The continuing crippling challenge of skeletal fluorosis – Case series and review of literature

Background

Skeletal fluorosis is a metabolic bone disease that results from the chronic ingestion of fluoride. Although there are national programs in place to raise awareness and curtail this disease condition, skeletal fluorosis continues to cause crippling deformities in areas where it continues to be endemic.

Method

ology: An observational study was undertaken at a university-affiliated teaching hospital in southern India. Clinical, biochemical features and densitometric variables including bone mineral density (BMD) and trabecular bone score (TBS) were assessed.

Results

All patients (n = 9) hailed from fluorosis-endemic Indian states and the source of drinking water was from a bore-well in all cases. The mean (±SD) age and BMI were 45.6(±11.0) years and 25.6 (±8.4) kg/m2 respectively. Dental mottling was present in five subjects. Five subjects each had vitamin D deficiency with osteomalacia. The mean (±SD) urine fluoride was 2.9(±1.4) ppm. The bone mineral density showed a sclerotic pattern, with the mean (±SD) TBS being 1.607 (±0.160). All patients were initiated on calcium and cholecalciferol supplements and those with osteomalacia were treated with calcitriol.

Conclusion

While fluorosis continues to be a challenge in endemic regions, the presence of osteomalacia proves to be a treatable component of the disease condition. There seems to be an unmet need for more aggressive defluoridation techniques and the provision of safe drinking water in susceptible individuals.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Clinical and Translational Endocrinology: Case Reports
Journal of Clinical and Translational Endocrinology: Case Reports Medicine-Endocrinology, Diabetes and Metabolism
CiteScore
1.10
自引率
0.00%
发文量
32
审稿时长
27 weeks
期刊介绍: The journal publishes case reports in a variety of disciplines in endocrinology, including diabetes, metabolic bone disease and osteoporosis, thyroid disease, pituitary and lipid disorders. Journal of Clinical & Translational Endocrinology Case Reports is an open access publication.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信